This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
billion in revenue by dispensing medicines to treat cancer, HIV, heart disease and other serious illnesses at prices that exceeded their estimated acquisition costs between 2017 and 2022. Specifically, the companies were able to generate more than $7.3 Continue to STAT+ to read the full story…
According to the New York Times, “Since 2017, tens of millions have been spent by the federal government on mass shooter training, and states have spent even more.”
Between 2017 and 2021, regulators in the U.S. Of 104 reports of supply chain issues with dozens of drugs, meaningful shortages were 40% less likely to occur in Canada than in the U.S., a new study found, and the difference was largely attributed to the approach taken by the Canadian government to the problem.
The company indicated that the investigation began in 2017 and picked up in intensity in late 2024 and early 2025. The SEC filing states that on Feb. Continue to STAT+ to read the full story…
The DOJ began looking into the company in 2017, according to Semler, but re-upped its investigation in late 2024 and early 2025. The deal would cap an investigation Semler first disclosed in February into whether federal health programs paid out improper claims based on the use of QuantaFlo, which would violate the False Claims Act.
billion in revenue by dispensing medicines to treat cancer, HIV, heart disease, and other serious illnesses at prices that exceeded their estimated acquisition costs between 2017 and 2022. Specifically, the companies were able to generate more than $7.3 A federal watchdog weighed in on the U.S.
Generics 2030: Three strategies to curb the downward spiral. Retrieved from [link] The Commonwealth Fund. Strategies That Delay Market Entry of Generic Drugs. Retrieved from [link] Bollyky, T. J., & Kesselheim, A. Ten challenges in the prescription drug marketand ten solutions. Retrieved from [link] Gottlieb, S.
From 2011 through 2017, Gilead held more than 17,300 speaker programs of which 9,500 were dinners to promote sales of HIV drugs that were supposed to be educational. The dinners were at expensive restaurants that federal authorities maintained were “wholly inappropriate” venues for such gatherings.
In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.
The DCAP was an initiative launched in 2017 to remove barriers to generic drug development, approval, and market entry (see our previous post here ). About one third of these PSGs are for complex products and many reflect what OGD and DPD learned about the science of equivalence from GDUFA-funded regulatory science research.
Chan School of Public Health researcher, noted, “Everything is clear, and there are no hidden fees” when it comes to generic drugs. By focusing on generics, we can take significant steps towards making medicines more affordable and improving public health. References: Accessible Medicines. Generic Drug Access & Savings in the U.S.
The facility was designed as a LEED Platinum-certified building when it was inaugurated in 2017. This certification highlights sustainable practices in operations and maintenance and marks a significant achievement for Lupin, making it one of the first Indian pharmaceutical companies to reach this milestone.
2017 Jun;32:660-6. Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. Journal of general internal medicine. PMID 28194688 D’Onofrio G, O’Connor PG, Pantalon MV, et al.
Acalabrutinib had previously received approval in 2017 as a single agent for this same indication. The recent application was granted both priority review and orphan drug designation.
per cent GDP target set in the National Health Policy (2017) and exploring tax incentives or PLI-like schemes for healthcare infrastructure development. Additionally, investments in AI for drug discovery, still in its nascent stage in India, hold immense transformative potential.
One study conducted in 2016-2017 found that 10% of new prescriptions for contraceptive pills and patches were written by pharmacists during that period. 1 Meredith also cited promising outcomes from states like Oregon.
An evaluation conducted by CMS during the initial implementation of pre-enrollment verification requirements in 2017 found that enrollment delays and disenrollments increased significantly without achieving meaningful reductions in improper enrollments. Finkelstein et al., 7 Benjamin D. Neumann et al., 12 Robert Dubois et al., 14 Munira Z.
Of the 13 antibiotics OK’d for the market between mid-2017 and 2023, only two belonged to a new class of drugs, the WHO reported last year. The pharma struck a development deal for Datroway worth up to $1 billion up front in 2020 and has estimated its peak sales could reach $5 billion.
In the 2017 book The Big Picture , author Sean Carroll seamlessly blends the scientific with the philosophical and comments that “life is not a substance, like water or rock; it’s a process, like fire or a wave crashing on the shore. Dutton; 2017. REFERENCES 1. The Big Picture: On the Origins of Life, Meaning, and the Universe Itself.
million global deaths recorded in 2017. Updated October 16, 2017. The data, which were published in Nephrology , also highlighted comparable safety among the 2 treatments. The global prevalence is estimated to be about 11% to 13%, with 697.5 million cases of all-stage disease CKD and 1.2 ClinicalTrials.gov identifier: NCT02044653.
Growth and Skills Levy – enabling greater training flexibility Since its introduction in 2017, the Apprenticeship Levy has generated over 21 billion from UK employers, increasing apprenticeship funding from 1.5 billion in 2017/18 to 2.5 billion in 2023/24.
5 (May 10, 2024): e240921, [link] 6 Medicare Payment Advisory Commission, Report to the Congress: Medicare and the Health Care Delivery System , Chapter 2, “Medicare Part B Drug Payment Policy Issues” (Washington, DC: MedPAC, June 2017), [link] www.medpac.gov/wp-content/uploads/import_data/scrape_files/docs/default- source/reports/jun17_ch2.pdf.
One patient started Inflectra in 2016 and 2017. The authors observed that 3807 patients had started on the infliximab originator and 795 were started on a biosimilar, with no clinical significance observed between the 2 groups. 1 Interestingly, there were similar rates of biosimilar initiation by age group every year except for 2020 ( p =.03),
CHMP’s re-examinations of recommendation approvals The European Commission requested a re-examination of theCHMPs negative opinion adopted in December 2017 for Aplidin (plitidepsin), a medicine intended to treat multiple myeloma.
Since 2017, the firm’s workforce in the US has expanded by 73 percent, facilitating 15 US Food and Drug Administration (FDA) approvals or indication expansions. UCB highlighted that eight of these have been granted in the past two years.
Established in July 2017, Axcelead DDP claims to be Japan’s first drug discovery solution provider, inheriting Takeda Pharmaceuticals drug discovery platform. The potential of protein degraders is vast, with the ability to treat drug-resistant conditions and reduce drug resistance and toxicity.
2017, November 17). References: National Community Pharmacists Association. Medication adherence in America: A national report card. link] Neiman, A. B., Ruppar, T., G., & Thorpe, P. G. CDC Grand Rounds: Improving medication adherence for chronic disease management—innovations and opportunities. T., & Bussell, J. K.
3 GlobalData’s analysis shows that the number of clinical trial investigators globally fell from approximately 128,303 in 2017-18 to 116,948 in 2023-24 – a decline of almost 10%. The ranks of trial site coordinators dropped even more steeply in these periods, dropping from approximately 56,036 to 40,472.
Updated July 14, 2017. If the bites worsen or signs of infection develop, if symptoms persist beyond a week, or if there are concerns about allergic reactions or fevers, he may need to visit a health care provider. 6 REFERENCES 1. Sun protection factor (SPF). Accessed May 12, 2025. Sunburn: treatment and prevention. Healthchildren.org.
Oxford Nanopore Technologies has been engaged in Indias genomic ecosystem since 2017. The companys upcoming office in Bengaluru will formalise and expand its commitment to the region through closer collaborations with researchers, clinicians, and public health institutions.
This same injectable omeprazole has been available from Bova in Australia and the UK since 2017. In partnership with the Bova group , Epicur launched a unique injectable omeprazole in December 2024 for equine veterinarians in the US.
Dive Insight: Since the FDA’s approval of Novartis’ Kymriah for leukemia in 2017, six more CAR-T therapies have reached market. These medicines are made from a patient’s own immune cells, extracted from the body and engineered in a lab to hunt down specific proteins found on the surface of malignant clones.
External Links CPG Management of Acne, 2012 eTG Complete - Information about Acne, 2022 Guidelines of care for the management of acne vulgaris, 2016 Light therapies for acne, 2016 AFP - Acne Vulgaris: Diagnosis and Treatment, 2019 Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007-2017, 2020
Department of Health and Human Services, December 2017. [link] [9] Pew Charitable Trusts, How to Improve Electronic Health Record Usability and Patient Safety (fact sheet, August 2016), [link] [10] Mohsen and Aziz, “The Blue Button Project,” 1d. [11] 11] Moreland, “Bridging the Gap.” [12] Harle, and Joshua R. 16] Nir Menachemi et al., “The
In addition, the TCI market is projected for significant growth, rising from $13m in 2017 to $30bn in 2030, says GlobalData. The majority of the T-cell immunotherapy (TCI) landscape comprises chimeric antigen receptor T-cell (CAR-T) immunotherapy products, accounting for 73% of all active TCIs, according to GlobalData.
Since 2017, the Alliance for Safe Online Pharmacies has been reporting that roughly 95% of online pharmacies are illegal or unsafe. Raising the alarm even higher is the fact that more consumers are buying medicines online, a market shift that occurred during COVID-19 and has continued to persist and grow.
Since 2017, 24 states have passed 38 laws targeting healthcare transparency , with a strong focus on unraveling the complex economics of pharmacy benefit managers (PBMs). Last week, President Trump signed yet another executive order , this time promising to make healthcare pricing more transparent.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content